RenehaVis consists of a sterile, pre-filled, ready-to-use dual-chamber glass syringe containing:

– Chamber 1:
Low Molecular Weight (LMW) Sodium Hyaluronate – 0.7 ml sterile Sodium Hyaluronate 2.2%, molecular weight 1 × 106 Da.
– Chamber 2:
High Molecular Weight (HMW) Sodium Hyaluronate – 0.7 ml sterile Sodium Hyaluronate 1.0%, molecular weight 2 × 106 Da.

RenehaVis is particularly effective in reducing knee joint pain and stiffness in patients suffering from synovial joint degeneration.

The high reliability of RenehaVis is due to its physicochemical properties: the LMW and HMW Sodium Hyaluronate contained in RenehaVis is a biopolymer composed of disaccharide units of N-acetylglucosamine and glucuronic acid, obtained through the biosynthesis of Streptococcus equi. It is identical to the Sodium Hyaluronate naturally found in synovial joints, but which may have been altered by degenerative or traumatic changes within the joint.

RenehaVis replenishes synovial Sodium Hyaluronate that has undergone alterations in molecular weight and concentration.

Report an adverse effect